Nick Haining
@nickhaining
Followers
3K
Following
2K
Statuses
1K
CSO and co-founder of @ArsenalBio via @DanaFarber, @broadinstitute, and @Merck. He/his.
Boston, MA
Joined October 2009
I’m lucky that I get to work with this team.
We are excited to announce our $325 million #SeriesC financing. This new investment will enable ArsenalBio's ongoing development efforts and scale our manufacturing capabilities to develop T-cell medicines. We thank the new investors along with our existing investors for their support in helping us to achieve our goal to defeat cancer. #celltherapy #patientsfirst
2
1
32
@BrianC_Miller @UNC_Lineberger @ArsenalBio In the future I’m going to insist that everyone sings before I give a talk. It’s the only way, really.
0
0
5
@MangusoLab @Nature @calico @abbvie Congratulations to the whole team across all the institutions on a huge advance chemically and therapeutically. More generally it suggests that long term funding of ambitious science partnered with with engaged drug hunters can make magic happen.
0
0
4
2
0
4
RT @TJJardinero: Proud to be one of said Braniacs! Looking forward to discussing our exciting work at #AACR2023
0
2
0
There’s some really awesome science going on at @ArsenalBio — come and meet the brainiacs building tomorrow’s cell therapy today at #AACR23
1
8
39
Well deserved award to a thoughtful and original scientist who has helped us all understand a lot about how T cells work and don’t work. Congrats @EJohnWherry !
We congratulate @EJohnWherry, of @PennMedicine on being recognized with the 2023 AACR-CRI Lloyd J. Old Award in Cancer Immunology. Learn more: @CancerResearch
0
0
28
@shaleklab @MIT @ChemistryMIT @MIT_IMES @kochinstitute Well done, you clever sausage, you. Delighted.
1
0
2
I’m so glad this experiment ended and was reported in my lifetime. Amazing.
4
5
90
RT @Masopust_Vezys: Authored by Andrew G. Soerens et al, we show that #Tcells are capable of proliferating in response to iterative stimula…
0
409
0
@IreneGhobrial @DanaFarber I think @BradEBernstein is often more alert than that. Although not always.
0
0
2
Four years ago, the founders had a bunch of ideas on a whiteboard and not much else. Today, @ArsenalBio has dosed the first patient with AB-1015, an engineered autologous T cell therapy for ovarian cancer. Incredibly proud of what the Arsenal team has accomplished. Onwards.
The first patient has been dosed with AB-1015 in a Phase 1, first-in-human clinical trial for patients with ovarian cancer that is resistant to platinum-based regimens. It is our first internally discovered T cell medicine to enter clinical development:
3
10
114
@facts___matter @NatImmunol @EJohnWherry @PennMedicine Love this story. Congratulations @facts___matter
1
0
3